USE OF ENDOTHELIAL RECEPTOR B INHIBITORS IN PREVENTION AND TREATMENT OF HUMAN CYTOMEGALOVIRUS INFECTION AND CMV-RELATED PATHOLOGIES SUCH AS CARDIOVASCULAR DISEASES AND CANCER
The present invention relates to an ETBR-inhibitor for use in the prevention or treatment of a HCMV infection or a diseases or conditions caused by HCMV.Linvention concerne un inhibiteur de ETBR pouvant servir dans la prévention ou le traitement dune infection par le HCMV ou de maladies ou détats provoqués par le HCMV.